CTRI/2018/05/013744Not yet recruiting未知
Evaluation of safety and efficacy of hydrogen peroxide stabilized cream for treatment of mild to moderate acne vulgaris in comparison with benzoyl peroxide (BP) gel,double blinded randomized control study
Aditi Tripathi0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.All patients willing to give consent.
- •2.All new untreated case of acne vulgaris.
- •3. Both male and female (15-30 years)Â
Exclusion Criteria
- •1.Not willing to give consent.
- •2.Acne vulgaris patient presenting with signs and symptoms of associated systemic syndromes like PCOD (patient will be send to gynaecology opd for evaluation ) , cushing syndrome.
- •3.Steriod induced acne vulgaris.
- •4.Pregnant ladies .
- •5.Patients with grade 3 & 4 acne.
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of Safety and efficacy of hydrogen peroxide 35% topical solution, in Comparision to cryotherapy in on treatment of patients with senile lentigo referring to Shohada-e-Tajrish and Loghman-e-Hakim hospital in 1397-98.IRCT20190519043632N1Shahid Beheshti University of Medical Sciences33
Not yet recruiting
Not Applicable
The effect of Saffron petal hydrogel on the prevention of radiotherapy-induced dermatitisRadiotherapy-induced mucositis is breast-conserving cancer patients.Acute radiodermatitis, Localized skin eruption due to drugs and medicamentL58.0, L27IRCT20180103038199N7Mashhad University of Medical Sciences80
Recruiting
Not Applicable
Hominax for improving sperm healthSperm healthAlternative and complementary medicineReproductive Health and Childbirth - Fertility including in vitro fertilisationAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12616000194460Max Biocare Pty Ltd62
Recruiting
Phase 3
Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N51Sina Darou Laboratories Company80
Completed
Phase 3
Evaluation of safety and efficacy of Controlled release Hydrochlorothiazide in stage I Essential HypertensioCTRI/2013/07/003793Ipca Laboratories Ltd Mumbai54